(Q45139511)

9 December 2017

title

Anti-inflammatory effect of PPARgamma in cultured human mesangial cells (English)

1 reference

9 December 2017

1 reference

Zuying Xiong

1

1 reference

9 December 2017

Haichang Huang

2

1 reference

9 December 2017

Jingzi Li

3

1 reference

9 December 2017

Youfei Guan

4

1 reference

9 December 2017

Haiyan Wang

5

1 reference

9 December 2017

publication date

1 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

26

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

497-505

1 reference

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

Peroxisome proliferator-activated receptor gamma1 expression in porcine white blood cells: dynamic regulation with acute endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-200031747

21 January 2018

Identifiers

DOI

10.1081/JDI-200031747

1 reference

release_zlguybnt4jhyfjy6ygmvlquxsa

9 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zlguybnt4jhyfjy6ygmvlquxsa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference